Adaptimmune Therapeutics plc Stock News

After William Blair and Needham gave Autolus Therapeutics (NASDAQ: AUTL) a Buy rating last month, the company received another Buy,

Mizuho Securities analyst Mara Goldstein reiterated a Buy rating on Neoleukin Therapeutics (NLTX – Research Report) yesterday and set a

JonesTrading analyst Soumit Roy initiated coverage with a Buy rating on Curis (CRIS – Research Report) today and set a

The lobster industry has been hit hard this year. Here's a recipe to help you do your bit to help them.

Au sommaire du Café des sports: 1/ Coupe d’Italie, Naples vainqueur ! La ville en liesse. La victoire d’un entraîneur Gennaro Gattuso ?

Mizuho Securities analyst Mara Goldstein reiterated a Buy rating on Autolus Therapeutics (AUTL – Research Report) today and set a

Stocks Analysis by Harry Boxer covering: Bed Bath & Beyond Inc, Ballard Power Systems Inc, Apache Corporation, Arena Pharmaceuticals Inc. Read Harry Boxer's latest article on Investing.com

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Armata Pharmaceuticals

As of late, it has definitely been a great time to be an investor in Adaptimmune Therapeutics plc (ADAP).

Adaptimmune Therapeutics (ADAP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Albireo Pharma

GlaxoSmithKline's years-long oncology resurgence is on track to have two new drugs approved in the US in mid-2020, after the company won a key first-line

Cancer is one of the most challenging conditions for investigational therapies to target because malignant cells are frequently able to disguise themselves as healthy cells, thereby surpassing detecti

As part of mental health awareness week and this year’s campaign of #bekind, TCR Tiverton Community Radio showcased children in the community who had showed kindness, caring and coping during the CO

The Arrowsic Board of Selectmen will review the decision at their bi-weekly meetings and vote to either open the conservation area or keep it closed.